The required elevator inspection types in the U.S. and Canada generally include CAT 1, CAT 3, and CAT 5, performed annually, ...

Infigratinib demonstrated antitumour activity in FGFR2 amplified gastric cancer with a 23.8% response rate and manageable safety profile.

(NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCE ® (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 3 ATLAS-UC induction-only study (Study 2) evaluating tulisokibart ...

State, city and county inspectors have cited Iowa restaurants and stores for hundreds of food-safety violations during the ...

The NWSL has updated its heat safety policy, and simplified hydration breaks, as the league prepares to return to play in the ...

(Nasdaq: EXEL) today announced results from the final analysis of the dual primary endpoint of overall survival (OS) in the subset of patients without active liver metastases (non-liver metastases, ...

Wave also expects to initiate new clinical trials evaluating WVE-007 as an incretin add-on and as post-incretin maintenance in the second half of 2026.

FDA-positive path for sonelokimab in HS, strong VELA data and BLA timing through 2026, plus more. Click for this MLTX update.

Deramiocel demonstrates durable skeletal and cardiac muscle benefit over five years in the HOPE-2 OLE studyPUL 2.0 year-over-year decline attenuated to approximately 1 pointFindings to be presented ...

BROADEN2 enrollment completed nearly six months ahead of anticipated timelines. KT-621 Phase 3 trials in AD planned to initiate by mid-2027. KT-621 BREADTH Phase 2b asthma trial o ...

Amid a big push from advocates for a ballot measure that would divert 25% of Portland's climate funds to police, a new city ...